List of Tables
Aids to access details current report period (2019-20) | |
Details of Accountable Authority during the current report period (2019-20) | |
Government funding for the supply of blood and blood products, 2010-11 to 2019-20 | |
Performance Criteria Qualitative Deliverable - provide a safe, secure and affordable supply of blood and blood related products and services | |
Performance Criteria Quantitative Deliverable - provide a safe, secure and affordable supply of blood and blood related products and services | |
Performance Criteria Qualitative Deliverable - drive performance improvement in the Australian blood sector | |
Performance Criteria Qualitative Deliverable - promote a best practice model of management and use of blood and blood related products and services | |
Performance Criteria Qualitative Deliverable - develop policy and provide policy advice on the sustainability of the blood sector | |
Performance Criteria Qualitative Deliverable - the National Blood Authority is a high performing organisation | |
Performance Criteria Quantitative Deliverable - the National Blood Authority is a high performing organisation | |
Blood and blood products purchased, by supplier, 2015-16 to 2019-20 | |
Fresh blood expenditure: increases over the last 10 years | |
Immunoglobulin growth | |
Lifeblood: selected key performance indicators, 2019-20 | |
CSL Behring performance under the NaFAA, 2019-20 | |
Imported Ig: Key performance indicators, by supplier, 2019-20 | |
Imported plasma and recombinant blood products: key performance indicators, by supplier, 2019-20 | |
NBA's performance in achieving business plan objectives, 2015-16 to 2019-20 | |
Australian Public Service Act ongoing employees current report period (2019-20) | |
Australian Public Service Act non-ongoing employees current report period (2019-20) | |
Australian Public Service Act ongoing employees previous report period (2018-19) | |
Australian Public Service Act non-ongoing employees previous report period (2018-19) | |
Australian Public Service Act employees by full time and part time status current report period (2019-20) | |
Australian Public Service Act employees by full time and part time status previous report period (2018-19) | |
Age demographic of NBA staff as at 30 June 2020 | |
All ongoing employees current report period (2019-20) | |
All non-ongoing employees current report period (2019-20) | |
All ongoing employees previous report period (2018-19) | |
All non-ongoing employees previous report period (2018-19) | |
Australian Public Service Act employment type by location current report period (2019-20) | |
Australian Public Service Act employment type by location previous report period (2018-19) | |
Australian Public Service Act employment arrangements current report period (2019-20) | |
Australian Public Service Act employment salary ranges by classification level (minimum/maximum) current report period (2019-20) | |
Information about remuneration for key management personnel | |
Information about remuneration for senior executives | |
Departmental and Administered funding and expenditure 2019-20: a summary | |
Key results in financial performance, 2015-16 to 2019-20 | |
Administered revenue, 2015-16 to 2019-20 | |
Key results of administered expenses, 2015-16 to 2019-20 | |
Number and expenditure on consultants current report period (2019-20) | |
Expenditure on consultancy services, 2015-16 to 2019-20 | |
Fresh blood components supplied under contract by Lifeblood, 2019-20 | |
Plasma and recombinant products supplied under contract 2019-20 | |
NBA environmental performance indicators | |
Agency resource statement | |
Agency expenses by outcome | |
Report on financial performance summary | |
List of requirements |
Visit
https://www.transparency.gov.au/annual-reports/national-blood-authority/reporting-year/2019-20-3